|
Urrego EG, Carmona-Bayonas A, González-Billalabeitia E, Ayala de la Peña F. Should anticoagulation therapy be withheld in patients with active cancer after 6 months of low-molecular weight heparin? J Clin Oncol. 2015 May 20;33(15):1713. doi: 10.1200/JCO.2014.60.6384. PubMed PMID: 25870093.
AÑO: 2015; IF: 20.982
|
25870093
|
Font C, Carmona-Bayonas A, Fernández-Martinez A, Beato C, Vargas A, Gascon P, Otero R. Outpatient management of pulmonary embolism in cancer: data on a prospective cohort of 138 consecutive patients. J Natl Compr Canc Netw. 2014 Mar 1;12(3):365-73. PubMed PMID: 24616542.
AÑO: 2014; IF: 4.178
|
|
Carmona-Bayonas A, Fonseca PJ, Font C, Martínez-García J, Torrella F, Urrego E, Castaño P, Navarrete A, Antonio-Rebolla M, Gómez JG, Vincente V, Ayala F. Bacteremia in adult cancer patients with apparently stable febrile neutropenia: data from a cohort of 692 consecutive episodes from a single institution. J Community Support Oncol. 2014 Sep;12(9):312-20. doi: 10.12788/jcso.0071. PubMed PMID: 25848908.
AÑO: 2014
|
|
Feliu J, Salud A, Safont MJ, García-Girón C, Aparicio J, Vera R, Serra O, Casado E, Jorge M, Escudero P, Bosch C, Bohn U, Pérez-Carrión R, Carmona A, Martínez-Marín V, Maurel J. First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study. Br J Cancer. 2014 Jul 15;111(2):241-8. doi: 10.1038/bjc.2014.346. PubMed PMID: 24946000; PubMed Central PMCID: PMC4102952.
AÑO: 2014; IF: 4.836
|
|
Carmona-Bayonas A, Font C, de la Peña FA. Stress-induced hyperglycemia is a valuable biomarker in febrile neutropenia. Rev Bras Hematol Hemoter. 2013;35(1):12-4. doi: 10.5581/1516-8484.20130006. PubMed PMID: 23580876; PubMed Central PMCID: PMC3621627.
AÑO: 2013
|